The novel approach of this peptide represents a major advance in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide639609.bloggazza.com/40680394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment